These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dectin-1 expression by macrophages and related antifungal mechanisms in a murine model of Sporothrix schenckii sensu stricto systemic infection. Jellmayer JA; Ferreira LS; Manente FA; Gonçalves AC; Polesi MC; Batista-Duharte A; Carlos IZ Microb Pathog; 2017 Sep; 110():78-84. PubMed ID: 28645771 [TBL] [Abstract][Full Text] [Related]
3. Skin Mast Cells Contribute to Jiao Q; Luo Y; Scheffel J; Geng P; Wang Y; Frischbutter S; Li R; Maurer M; Zhao Z Front Immunol; 2020; 11():469. PubMed ID: 32265923 [No Abstract] [Full Text] [Related]
4. Antibodies Against Sporothrix schenckii Enhance TNF-α Production and Killing by Macrophages. Franco Dde L; Nascimento RC; Ferreira KS; Almeida SR Scand J Immunol; 2012 Feb; 75(2):142-6. PubMed ID: 21923739 [TBL] [Abstract][Full Text] [Related]
5. Response of macrophage Toll-like receptor 4 to a Sporothrix schenckii lipid extract during experimental sporotrichosis. Sassá MF; Saturi AE; Souza LF; Ribeiro LC; Sgarbi DB; Carlos IZ Immunology; 2009 Oct; 128(2):301-9. PubMed ID: 19740386 [TBL] [Abstract][Full Text] [Related]
6. Chitin-rich heteroglycan from Sporothrix schenckii sensu stricto potentiates fungal clearance in a mouse model of sporotrichosis and promotes macrophages phagocytosis. Huang L; Zhang J; Du W; Liang Z; Li M; Wu R; Chen S; Hu X; Huang H BMC Microbiol; 2021 Jun; 21(1):190. PubMed ID: 34171998 [TBL] [Abstract][Full Text] [Related]
7. Sporothrix brasiliensis induces a more severe disease associated with sustained Th17 and regulatory T cells responses than Sporothrix schenckii sensu stricto in mice. Batista-Duharte A; Téllez-Martínez D; Roberto de Andrade C; Portuondo DL; Jellmayer JA; Polesi MC; Carlos IZ Fungal Biol; 2018 Dec; 122(12):1163-1170. PubMed ID: 30449354 [TBL] [Abstract][Full Text] [Related]
8. Innate Immune Responses to Sporothrix schenckii: Recognition and Elimination. Lin P; Zhang J; Xie G; Li J; Guo C; Lin H; Zhang Y Mycopathologia; 2023 Apr; 188(1-2):71-86. PubMed ID: 36329281 [TBL] [Abstract][Full Text] [Related]
9. Sporothrix schenckii yeasts induce ERK pathway activation and secretion of IL-6 and TNF-α in rat mast cells, but no degranulation. Romo-Lozano Y; Hernández-Hernández F; Salinas E Med Mycol; 2014 Nov; 52(8):862-8. PubMed ID: 25262023 [TBL] [Abstract][Full Text] [Related]
10. Natural killer cells are pivotal for in vivo protection following systemic infection by Sporothrix schenckii. Ferreira LS; Portuondo DL; Polesi MC; Carlos IZ Immunology; 2018 Dec; 155(4):467-476. PubMed ID: 30030839 [TBL] [Abstract][Full Text] [Related]
11. The NLRP3 inflammasome contributes to host protection during Sporothrix schenckii infection. Gonçalves AC; Ferreira LS; Manente FA; de Faria CMQG; Polesi MC; de Andrade CR; Zamboni DS; Carlos IZ Immunology; 2017 Jun; 151(2):154-166. PubMed ID: 28140444 [TBL] [Abstract][Full Text] [Related]
13. Transient Foxp3(+) regulatory T-cell depletion enhances protective Th1/Th17 immune response in murine sporotrichosis caused by Sporothrix schenckii. Batista-Duharte A; Téllez-Martínez D; de Andrade CR; Polesi MC; Portuondo DL; Carlos IZ Immunobiology; 2020 Sep; 225(5):151993. PubMed ID: 32962813 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory activity of Vismia guianensis (Aubl.) Pers. extracts and antifungal activity against Sporothrix schenckii. Oliveira AH; de Oliveira GG; Carnevale Neto F; Portuondo DF; Batista-Duharte A; Carlos IZ J Ethnopharmacol; 2017 Jan; 195():266-274. PubMed ID: 27856302 [TBL] [Abstract][Full Text] [Related]
15. Mast cell activation by conidia of Sporothrix schenckii: role in the severity of infection. Romo-Lozano Y; Hernández-Hernández F; Salinas E Scand J Immunol; 2012 Jul; 76(1):11-20. PubMed ID: 22486186 [TBL] [Abstract][Full Text] [Related]
16. Mouse bone marrow-derived dendritic cells can phagocytize the Sporothrix schenckii, and mature and activate the immune response by secreting interleukin-12 and presenting antigens to T lymphocytes. Kusuhara M; Qian H; Li X; Tsuruta D; Tsuchisaka A; Ishii N; Ohata C; Furumura M; Hashimoto T J Dermatol; 2014 May; 41(5):386-92. PubMed ID: 24750442 [TBL] [Abstract][Full Text] [Related]
17. Differential recognition and cytokine induction by the peptidorhamnomannan from Sporothrix brasiliensis and S. Schenckii. Kischkel B; Lopes-Bezerra L; Taborda CP; Joosten LAB; Dos Santos JC; Netea MG Cell Immunol; 2022 Aug; 378():104555. PubMed ID: 35696852 [TBL] [Abstract][Full Text] [Related]
18. A cell wall protein-based vaccine candidate induce protective immune response against Sporothrix schenckii infection. Portuondo DL; Batista-Duharte A; Ferreira LS; Martínez DT; Polesi MC; Duarte RA; de Paula E Silva AC; Marcos CM; Almeida AM; Carlos IZ Immunobiology; 2016 Feb; 221(2):300-9. PubMed ID: 26547105 [TBL] [Abstract][Full Text] [Related]
19. The predominance of alternatively activated macrophages following challenge with cell wall peptide-polysaccharide after prior infection with Sporothrix schenckii. Alegranci P; de Abreu Ribeiro LC; Ferreira LS; Negrini Tde C; Maia DC; Tansini A; Gonçalves AC; Placeres MC; Carlos IZ Mycopathologia; 2013 Aug; 176(1-2):57-65. PubMed ID: 23686275 [TBL] [Abstract][Full Text] [Related]
20. Differential induction of Th1-prone immunity by human dendritic cells activated with Sporothrix schenckii of cutaneous and visceral origins to determine their different virulence. Uenotsuchi T; Takeuchi S; Matsuda T; Urabe K; Koga T; Uchi H; Nakahara T; Fukagawa S; Kawasaki M; Kajiwara H; Yoshida S; Moroi Y; Furue M Int Immunol; 2006 Dec; 18(12):1637-46. PubMed ID: 17035348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]